Lead- and drug-like compounds: the rule-of-five revolution

Christopher A. Lipinski(Pfizer (United States))

Drug Discovery Today Technologies

December 1, 2004

10.1016/j.ddtec.2004.11.007

Cited by 6,038

Abstract

Related Papers

No related papers found

Powered by citation graph analysis